Navigation Links
Pachmate DGH55

ProductsPachmate DGH55
Company DGH Technologies, Inc.
Item Pachmate DGH55
Features 
  • Measurement Range:
  • Standard: 200 microns to 1100 microns
  • Flap Option: 95 microns to 1100 microns
  • Accuracy: 5 microns
  • Resolution: 1 micron
  • Internal Clock Accuracy: 0.002%
  • Size: Length 6.92" (175 mm) x Width 1.69" (43 mm) Depth .83 (21 mm)
  • Weight: 3.6 Ounces (112 grams)
  • Power Requirement: Two (2) AAA batteries
Description The DGH Technology, Inc. Pachmate (DGH 55) is the ultimate in portable pachymeters. Only 6.9 inches long and 3.6 ounces in weight. The Pachmate is a handheld pachymeter that gives accurate reliable corneal thickness measurements. The Pachmate will easily fit in a lab coat or shirt pocket. The Pachmate is rugged in design and one of the worlds smallest portable pachymeters.
Info DGH Technologies, Inc.Call DGH Technologies, Inc. to buy products (US and Canada only; other locations use number below) USACanada1-866-439-1150

Customer Service: 800-722-3883
Web site: http://dghkoi.com/

Related medicine products :

1. Resuscitation Exhalation Port Filter
2. Silicone Oil Cannula System - 20 Gauge
3. Silicone Oil Cannula System - 19 Gauge
4. SuperVu Galilean System
5. KOWA nonmyd 7 / VK-2 Digital Imaging System
6. KOWA nonmyd a-D / VK-2 Digital Imaging System
7. Refraction System RT-2100
8. Odyssey Phacoemulsification System
9. SIStem Phacoemulsification System
10. Precisionist Phacoemulsification System
11. Photon Laser Phacoemulsification System
Breaking Medicine Technology:Free Wheelchair Mission Breaks List of Top 60 OC Nonprofits in 2009 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 2Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 3Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 4Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 5Novartis Tasigna(R) (nilotinib) Trial Shows Superior Results to Glivec(R) (imatinib) in Newly Diagnosed, Chronic Phase Chronic Myeloid Leukaemia 6Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 2Biomatrica Launches DNAgard(TM) for Room Temperature Storage of Tissues and Cell Culture 3Cancer survivors at greater risk of birth complications 3B special monitoring needed 50498 1Cancer survivors at greater risk of birth complications 3B special monitoring needed 50498 2Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 1Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 2Meltzer and Yancy to Lead American Heart Association in 2009 10 50496 3Calling All Runners 3A Join the Fight Against Cancer 50493 1Calling All Runners 3A Join the Fight Against Cancer 50493 2